PAMS
XLRN

Pictet Asset Management (Switzerland)’s Acceleron Pharma XLRN Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,765
Closed -$2.54M – 1840
2021
Q3 		$2.54M Buy
+14,765
New +$1.93M ﹤0.01% 958

Pictet Asset Management (Switzerland)'s XLRN Position: Q4 2021 in Review

Pictet Asset Management (Switzerland) sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 14,765 shares — an estimated $2.54M sold.

Pictet Asset Management (Switzerland) first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $2.54M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Pictet Asset Management (Switzerland) reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 14,765 Acceleron Pharma shares in Q4 2021, an estimated $2.54M.
  • Pictet Asset Management (Switzerland) first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Pictet Asset Management (Switzerland)'s Acceleron Pharma position peaked at $2.54M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q4 2021, filed 10 Feb 2022.